Literature DB >> 9579163

Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis.

L P Ormerod1.   

Abstract

Prophylaxis of tuberculosis in children with four month (n = 53) and three month regimens (n = 213) of rifampicin and isoniazid from 1987 to 1996 were tolerated without any toxicity. The reduction in the proportion of paediatric tuberculosis, which was seen after the introduction of chemoprophylaxis with longer regimens in 1981, was maintained with the shorter duration regimens. Altered immigration patterns and a fall in the proportion of infectious tuberculosis, as defined by sputum culture positivity, have been excluded as factors in the reduced paediatric proportion of tuberculosis. The data show such regimens have little toxicity and provide indirect evidence that three months chemoprophylaxis may be as effective as longer regimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579163      PMCID: PMC1717463          DOI: 10.1136/adc.78.2.169

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  3 in total

1.  Tuberculosis screening and prevention in new immigrants 1983-88.

Authors:  L P Ormerod
Journal:  Respir Med       Date:  1990-07       Impact factor: 3.415

2.  Frequency and type of reactions to antituberculosis drugs: observations in routine treatment.

Authors:  L P Ormerod; N Horsfield
Journal:  Tuber Lung Dis       Date:  1996-02

3.  Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing.

Authors:  L P Ormerod
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

  3 in total
  13 in total

Review 1.  Paediatric tuberculosis.

Authors:  W Hoskyns
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

Review 2.  Latent tuberculosis in children: diagnosis and management.

Authors:  Meenu Singh; Arushi Gahlot Saini; Nidhi Anil; Amit Aggarwal
Journal:  Indian J Pediatr       Date:  2010-12-03       Impact factor: 1.967

Review 3.  Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 4.  Tuberculosis in Children.

Authors:  Devan Jaganath; Jeanette Beaudry; Nicole Salazar-Austin
Journal:  Infect Dis Clin North Am       Date:  2022-03       Impact factor: 5.905

Review 5.  [Tuberculosis-current therapeutic principles].

Authors:  U Greinert; P Zabel
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743

6.  Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane.

Authors:  Christine Nguyen; Noel R Rose; Dolores B Njoku
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-08       Impact factor: 2.839

7.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

8.  Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.

Authors:  Tianyu Zhang; Ming Zhang; Ian M Rosenthal; Jacques H Grosset; Eric L Nuermberger
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

9.  Antituberculosis drug-induced hepatotoxicity in children.

Authors:  Peter R Donald
Journal:  Pediatr Rep       Date:  2011-06-16

Review 10.  Recent developments in treatment of latent tuberculosis infection.

Authors:  Dick Menzies; Hamdan Al Jahdali; Badriah Al Otaibi
Journal:  Indian J Med Res       Date:  2011-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.